DK3738584T3 - Granulat indeholdende eslicarbazepinacetat, fremstilling deraf, farmaceutiske præparater indeholdende dette og anvendelse af disse - Google Patents

Granulat indeholdende eslicarbazepinacetat, fremstilling deraf, farmaceutiske præparater indeholdende dette og anvendelse af disse Download PDF

Info

Publication number
DK3738584T3
DK3738584T3 DK20174336.6T DK20174336T DK3738584T3 DK 3738584 T3 DK3738584 T3 DK 3738584T3 DK 20174336 T DK20174336 T DK 20174336T DK 3738584 T3 DK3738584 T3 DK 3738584T3
Authority
DK
Denmark
Prior art keywords
eslicarbazepinacetate
preparation
pharmaceutical preparations
granules
preparations containing
Prior art date
Application number
DK20174336.6T
Other languages
English (en)
Inventor
Pál Fekete
János Bajdik
Lívia Gál
Zsolt Öszi
Original Assignee
Meditop Gyogyszeripari Korlatolt Felelossegu Tarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meditop Gyogyszeripari Korlatolt Felelossegu Tarsasag filed Critical Meditop Gyogyszeripari Korlatolt Felelossegu Tarsasag
Application granted granted Critical
Publication of DK3738584T3 publication Critical patent/DK3738584T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DK20174336.6T 2019-05-14 2020-05-13 Granulat indeholdende eslicarbazepinacetat, fremstilling deraf, farmaceutiske præparater indeholdende dette og anvendelse af disse DK3738584T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1900153A HUP1900153A1 (hu) 2019-05-14 2019-05-14 Eszlikarbazepin-acetát tartalmú granulátum, ennek elõállítása, ezt tartalmazó egyéb gyógyszerkészítmények, és ezek alkalmazása

Publications (1)

Publication Number Publication Date
DK3738584T3 true DK3738584T3 (da) 2022-10-03

Family

ID=89992897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20174336.6T DK3738584T3 (da) 2019-05-14 2020-05-13 Granulat indeholdende eslicarbazepinacetat, fremstilling deraf, farmaceutiske præparater indeholdende dette og anvendelse af disse

Country Status (9)

Country Link
EP (1) EP3738584B1 (da)
DK (1) DK3738584T3 (da)
ES (1) ES2927618T3 (da)
HR (1) HRP20221165T1 (da)
HU (2) HUP1900153A1 (da)
PL (1) PL3738584T3 (da)
PT (1) PT3738584T (da)
RS (1) RS63587B1 (da)
SI (1) SI3738584T1 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
ES2903037T3 (es) 2015-12-18 2022-03-30 Jubilant Generics Ltd Formas de dosificación orales sólidas de eslicarbazepina

Also Published As

Publication number Publication date
PT3738584T (pt) 2022-09-26
SI3738584T1 (sl) 2022-11-30
EP3738584A1 (en) 2020-11-18
ES2927618T3 (es) 2022-11-08
PL3738584T3 (pl) 2022-11-14
RS63587B1 (sr) 2022-10-31
HUE059904T2 (hu) 2023-01-28
HUP1900153A1 (hu) 2020-11-30
EP3738584B1 (en) 2022-06-29
HRP20221165T1 (hr) 2022-11-25

Similar Documents

Publication Publication Date Title
IL288204A (en) Protein-targeted compounds and their pharmaceutical preparations and their medical applications
DK3775091T3 (da) Stabiliserede fluorolefinsammensætninger og fremgangsmåder til fremstilling, oplagring og anvendelse deraf
EP3623389A4 (en) FUSION PROTEIN WITH TGF RECEPTOR AND ITS MEDICAL USES
DK3634965T3 (da) Radiofarmaceutiske lægemidler, radiobilleddannelsesmidler og anvendelser deraf
IL275798A (en) Methods for antibody drug conjugation, purification and formulation
DK3347472T3 (da) Sammensætninger som indeholder cyp76ad1- clade polypeptider og anvendelse heraf.
DK3313817T3 (da) Bicycliske derivater, fremgansmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende disse
SG11202009150RA (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
DK3368554T3 (da) Langtidsvirkende fgf21-fusionsproteiner og farmaceutisk sammensætning omfattende samme
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK1448591T3 (da) 17-alpha-alkyl-17-beta-oxy-estratriener og mellemprodukter til fremstilling heraf, anvendelse af 17-alpha-alkyl-17-beta-oxy-estratriener til fremstilling af lægemidler samt farmaceutiske præparater
EP3491026A4 (en) HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS
DK3275895T3 (da) Neuropilin-1-specifikt bindingspeptid, fusionsprotein fusioneret dermed, og anvendelse deraf
DK2617714T3 (da) Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf
DK3873600T3 (da) Pyridinylsulfonamidderivater, farmaceutiske sammensætninger og anvendelse deraf
EP3842534A4 (en) NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID AND METHOD OF USE THEREOF
DK3625319T3 (da) Belagte granulater, anvendelse deraf og vaske- og rengøringsmidler indeholdende disse
IL268821A (en) Antibody drug conjugates based on HDAC inhibitors and use in therapy
DK3744316T3 (da) Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
EP3693358A4 (en) HETEROARYL COMPOUND CONTAINING NITROGEN, AND ITS PHARMACEUTICAL USE
IL277573A (en) Antibody conjugates of cMET monoclonal binding agents and uses thereof
EP3670500A4 (en) CHEMICAL COMPOUND, PHARMACEUTICAL COMPOSITION OF IT, CORRESPONDING USE AND APPLICATION
EP3845560A4 (en) ANTIBODIES TO IL-1?, PHARMACEUTICAL COMPOSITION AND USE THEREOF
DK4023651T3 (da) Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme